Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Sientra, Proteon Therapeutics, Paratek Pharmaceuticals, Cempra, Chiasma. These five stock positions account for 67.53% of Abingworth's total stock portfolio.
- Added to shares of these 3 stocks: Novan, Histogenics Corp Cmn, Anthera Pharmaceutcls.
- Started 2 new stock positions in Histogenics Corp Cmn, Novan.
- Reduced shares in these 3 stocks: Tobira Therapeutics Inc Common Stock Usd 0.0001 (-$7.38M), Aurinia Pharmaceuticals, Epirus Biopharmaceuticals In.
- Sold out of its positions in Epirus Biopharmaceuticals In, Tobira Therapeutics Inc Common Stock Usd 0.0001.
- As of Sept. 30, 2016, Abingworth has $104.33M in assets under management (AUM). Assets under management grew from a total value of $95.50M to $104.33M.
- Independent of market fluctuations, Abingworth was a net seller by $2.82M worth of stocks in the most recent quarter.
Abingworth portfolio companies for September 2016 quarter
|Company (Ticker)||Portfolio Weight||Share Count||Price||Last Trade|
|Cellectis S A sponsored ads||2.31||100000||24.07||0.00|
|Anthera Pharmaceutcls||1.47||512036 +16.00%||2.99||0.00|
|Aurinia Pharmaceuticals||1.32||437994 -14.00%||3.14||0.00|
|Histogenics Corp Cmn||0.52||176904 NEW||3.07||0.00|
|OncoGenex Pharmaceuticals (OGXI)||0.19||396104||0.49||2.23|
Past 13F-HR SEC Filings for Abingworth
- Abingworth 2016 Q2 filed Aug. 12, 2016
- Abingworth 2015 Q4 filed Feb. 16, 2016
- Abingworth 2015 Q3 filed Nov. 13, 2015
- Abingworth 2014 Q4 filed Feb. 13, 2015
- Abingworth 2014 Q3 amended filed Nov. 25, 2014
- Abingworth 2014 Q1 filed May 21, 2014
- Abingworth 2013 Q2 filed Aug. 14, 2013
- Abingworth 2013 Q1 filed May 15, 2013
- Abingworth 2012 Q4 filed Feb. 13, 2013
- Abingworth 2012 Q3 filed Nov. 7, 2012
- Abingworth 2012 Q1 filed May 14, 2012
- Abingworth 2011 Q4 filed Feb. 7, 2012
- Abingworth 2011 Q3 filed Nov. 14, 2011
- Abingworth 2011 Q1 filed May 13, 2011
- Abingworth 2010 Q4 filed Feb. 14, 2011